These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 34522585)

  • 41. Two-dimensional cancer theranostic nanomaterials: Synthesis, surface functionalization and applications in photothermal therapy.
    Murugan C; Sharma V; Murugan RK; Malaimegu G; Sundaramurthy A
    J Control Release; 2019 Apr; 299():1-20. PubMed ID: 30771414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Graphene-based nanocomposites: synthesis and their theranostic applications.
    Madni A; Noreen S; Maqbool I; Rehman F; Batool A; Kashif PM; Rehman M; Tahir N; Khan MI
    J Drug Target; 2018 Dec; 26(10):858-883. PubMed ID: 29424250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
    Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y
    Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
    Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
    Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exosome Biochemistry and Advanced Nanotechnology for Next-Generation Theranostic Platforms.
    Yang B; Chen Y; Shi J
    Adv Mater; 2019 Jan; 31(2):e1802896. PubMed ID: 30126052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Responsive Polymer Brush Design and Emerging Applications for Nanotheranostics.
    Li D; Xu L; Wang J; Gautrot JE
    Adv Healthc Mater; 2021 Mar; 10(5):e2000953. PubMed ID: 32893474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Light stimulus responsive nanomedicine in the treatment of oral squamous cell carcinoma.
    Fan HY; Zhu ZL; Zhang WL; Yin YJ; Tang YL; Liang XH; Zhang L
    Eur J Med Chem; 2020 Aug; 199():112394. PubMed ID: 32402938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design and Functionalization of the NIR-Responsive Photothermal Semiconductor Nanomaterials for Cancer Theranostics.
    Huang X; Zhang W; Guan G; Song G; Zou R; Hu J
    Acc Chem Res; 2017 Oct; 50(10):2529-2538. PubMed ID: 28972736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biomolecule-functionalized nanoformulations for prostate cancer theranostics.
    Pranav ; Laskar P; Jaggi M; Chauhan SC; Yallapu MM
    J Adv Res; 2023 Sep; 51():197-217. PubMed ID: 36368516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities.
    Siafaka PI; Okur NÜ; Karantas ID; Okur ME; Gündoğdu EA
    Asian J Pharm Sci; 2021 Jan; 16(1):24-46. PubMed ID: 33613728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioresponsive carbon nano-gated multifunctional mesoporous silica for cancer theranostics.
    Prasad R; Aiyer S; Chauhan DS; Srivastava R; Selvaraj K
    Nanoscale; 2016 Feb; 8(8):4537-46. PubMed ID: 26753966
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanotheranostics for Cancer Therapy and Detection: State of the Art.
    Paliwal SR; Kenwat R; Maiti S; Paliwal R
    Curr Pharm Des; 2020; 26(42):5503-5517. PubMed ID: 33200696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The upcoming field of theranostic nanomedicine: an overview.
    Prabhu P; Patravale V
    J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biodegradable Inorganic Nanoparticles for Cancer Theranostics: Insights into the Degradation Behavior.
    Zhou H; Ge J; Miao Q; Zhu R; Wen L; Zeng J; Gao M
    Bioconjug Chem; 2020 Feb; 31(2):315-331. PubMed ID: 31765561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biomimetic "Nanoplatelets" as a Targeted Drug Delivery Platform for Breast Cancer Theranostics.
    Li L; Fu J; Wang X; Chen Q; Zhang W; Cao Y; Ran H
    ACS Appl Mater Interfaces; 2021 Jan; 13(3):3605-3621. PubMed ID: 33449625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Review of Theranostics Applications and Toxicities of Carbon Nanomaterials.
    Gupta N; Rai DB; Jangid AK; Kulhari H
    Curr Drug Metab; 2019; 20(6):506-532. PubMed ID: 30251600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two-Dimensional Antimonene-Based Photonic Nanomedicine for Cancer Theranostics.
    Tao W; Ji X; Zhu X; Li L; Wang J; Zhang Y; Saw PE; Li W; Kong N; Islam MA; Gan T; Zeng X; Zhang H; Mahmoudi M; Tearney GJ; Farokhzad OC
    Adv Mater; 2018 Sep; 30(38):e1802061. PubMed ID: 30043416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional biomimetic nanoparticles for drug delivery and theranostic applications in cancer treatment.
    Li L; Wang J; Kong H; Zeng Y; Liu G
    Sci Technol Adv Mater; 2018; 19(1):771-790. PubMed ID: 30815042
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-metallic nanomaterials in cancer theranostics: a review of silica- and carbon-based drug delivery systems.
    Chen YC; Huang XC; Luo YL; Chang YC; Hsieh YZ; Hsu HY
    Sci Technol Adv Mater; 2013 Aug; 14(4):044407. PubMed ID: 27877592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protein nanocomposites: Special inferences to lysozyme based nanomaterials.
    Sarkar S; Gulati K; Mishra A; Poluri KM
    Int J Biol Macromol; 2020 May; 151():467-482. PubMed ID: 32084483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.